On March 7, 2006, in room 2205 of the (then new) White Oak FDA facility, Prof. Trevor Marshall delivered a lecture in FDA's Center for Drug Evaluation and Review (CDER) "Visiting Professor" series. The topic was how ARBs and Statins affect a lot more of the body than just the receptors they are thought to target ('dirty drugs", in the words of one FDA participant).
A PDF copy of the slides is available at:
http://autoimmunityresearch.org/fda_visiting-professor_7mar06_144dpi.pdf
.
Link to this comment:
All Comments (0)